Genitourinary Radiology: Page 8

SNMMI highlights prostate cancer study

By AuntMinnie.com staff writers

A recent study highlighted by the Society for Nuclear Medicine and Molecular Imaging (SNMMI) presents a new PET scoring system for predicting whether prostate cancer patients will respond to treatment with lutetium-177 prostate-specific membrane antigen-617.

April 20, 2023

PET/CT key to imaging patients with prostate cancer

By Will Morton

PET/CT imaging with novel radiotracers has emerged over the past several years as a first-line approach for diagnosing and monitoring treatments in patients with prostate cancer, according to an April 16 presentation at ARRS 2023 in Honolulu, HI.

April 18, 2023

Racial disparities persist in genitourinary clinical trials

By Will Morton

Racial disparities persist in genitourinary clinical trials of new biologic drugs and PET imaging radiotracers, according to a study published April 13 in Current Problems in Cancer.

April 16, 2023

Advantis gets FDA clearance for MRI analysis software

By AuntMinnie.com staff writers

Imaging software developer Advantis Medical Imaging has garnered U.S. Food and Drug Administration (FDA) clearance for its Advantis Platform brain and prostate MRI analysis software.

April 13, 2023

PET tracer for prostate cancer performs well in phase III trial

By Will Morton

PET/CT imaging with F-18 PSMA-1007 detects significantly more prostate cancer than imaging using the standard F-18 fluorocholine radiotracer, according to clinical results published in the April issue of the Journal of Nuclear Medicine.

April 13, 2023

MRI-targeted biopsy finds clinically significant prostate cancers

By Kate Madden Yee

MRI-targeted biopsy prompted by elevated prostate-specific antigen (PSA) levels identifies fewer clinically insignificant prostate cancers than systemic biopsy, according to a paper published April 4 in the Annals of Internal Medicine.

April 5, 2023

HistoSonics highlights first patient treated in CAIN trial

By AuntMinnie.com staff writers

HistoSonics has announced that the first kidney cancer patient has been treated in Leeds, U.K., using the company's histotripsy platform.

March 29, 2023

Bot Image's prostate MRI AI software wins new clearance

By AuntMinnie.com staff writers

MRI software developer Bot Image has secured an expanded clearance from the U.S. Food and Drug Administration clearance for its ProstatID AI software.

March 27, 2023

Accuray highlights prostate cancer treatment trial results

By AuntMinnie.com staff writers

Accuray is highlighting clinical results that show that, compared to surgery, stereotactic body radiation therapy better preserves urinary continence and sexual function in men with localized prostate cancer.

March 26, 2023

Simple x-ray protocol reduces radiation in obese patients

By Will Morton

Having obese patients use handheld cotton bands to move belly fat during pelvic x-ray exams can reduce their radiation exposure and improve image quality, according to a study published March 17 in Radiography.

March 26, 2023

Men report improved symptoms after enlarged prostate procedure

By Will Morton

Minimally invasive prostate artery embolization is an effective long-term treatment for men with enlarged prostate glands, according to researchers at a February 28 news conference held by the Society of Interventional Radiology.

March 1, 2023

Enrollment complete in Ascelia's new contrast agent trial

By AuntMinnie.com staff writers

Ascelia Pharma said it reached a milestone with enrollment now complete in its phase III study for Orviglance, a new MRI contrast agent for patients with kidney impairment.

February 28, 2023

Previous Page

Page 8 of 93

Next Page